SpaceX Headed for $250 or Wildly Overvalued: Oppenheimer and Michael Burry Disagree

SpaceX trades at $179 versus Oppenheimer’s $250 target, while Michael Burry says the stock is "too expensive" to short but is not currently positioned either way. Oppenheimer’s bullish case rests on AI vertical integration, including a $60 billion Cursor acquisition and projected Q4 2026 AI revenue of $8.75 billion, while Burry highlights a $2.8 trillion market cap, $18.7 billion in 2025 revenue, and a $4.27 billion Q1 loss. The article also notes heavy options activity and weakening retail sentiment, suggesting a volatile, sentiment-driven tape rather than a clear fundamental catalyst.

Analysis

The market is effectively repricing SpaceX as a three-layer optionality stack: AI monetization, launch dominance, and long-dated strategic assets. That makes the equity unusually sensitive to narrative convexity, but also to any evidence that one layer is less monetizable than the market is assuming. In practice, the key second-order effect is that a high-profile AI integration story can inflate terminal multiple assumptions across adjacent private-market assets, forcing investors to buy not just earnings growth but also scarcity premium.

The real risk is not that the company fails to grow; it is that growth arrives with poor capital efficiency and persistent balance-sheet strain. A large accumulated deficit combined with continued losses means every incremental dollar of revenue has to overcome both operating drag and a valuation base that is already discounting multiple end-markets at once. That creates a fragile setup: even modest disappointment in AI ARR conversion, launch cadence, or funding terms can compress the multiple faster than fundamentals can catch up.

Shorts are also structurally disadvantaged by derivatives demand, which can keep implied volatility elevated and make outright bearish expression expensive. That does not make the stock unshortable; it means the best way to express skepticism is likely through defined-risk structures or by fading strength after volatility compresses. The consensus is missing that 'too expensive to short' is not a bullish signal — it often marks a market where position-taking is crowded on both sides and price discovery becomes highly reflexive.

The most important catalyst window is the next 2-6 months, not the long-term moonshot narrative. Investors should watch whether AI revenue ramps on a cadence that justifies the current private-market markup, because if that path slows, the tape can de-rate before any of the long-duration bull case matters. Conversely, if financing conditions remain loose and options flow stays one-sided, the stock can overshoot fundamentals for longer than skeptics expect.

Key Decisions for Investors

• Avoid outright shorting SPCX into elevated implied volatility; use a defined-risk bearish structure such as a put spread 3-9 months out, sized small, to express valuation skepticism without paying unlimited carry.
• Fade rallies only after a volatility reset: if SPCX stabilizes and 30-day realized vol compresses, initiate a tactical short against strength with a tight stop above the prior gap high; target a 15-20% mean-reversion move over 4-8 weeks.
• For long-only exposure, keep position size below normal high-beta limits until there is at least one clean quarter of AI revenue execution; the risk/reward is poor for full-size ownership before the market proves monetization durability.
• Monitor BRK.B as a sentiment proxy for 'quality at any price' rotation; if high-duration private-market names keep de-rating, pair long cash-generative large caps vs short speculative growth baskets over the next 1-3 months.
• If options premiums on SPCX cheapen materially, consider a small speculative long call spread rather than stock; the upside is convex but the premium paid should be capped given binary valuation risk.